Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Dermopharmaceutical Formulations
An affiliate of
Table of content
1 Dermopharmaceutical market
3 Emulsology Theory
4 Emulsology Application
*Transdermal
That goes through the derm. All drug forms applied on
the skin and whose target is beyond the derma
(hormonal patches for instance). Some transdermal
drugs are systemic (hormons) and some acts localy
(anti-inflammatory)
*Cutaneous form
Preparation for skin application aiming at delivering
API locally or through the skin.
1 Dermopharmaceutical
market
Dermopharmaceutical
Market
Pharmaceutical market:
824 billion $ in 2010 (620 billion €)
A 4 to 7% growth is expected until 2013, especially in new
markets (Central Europe, AAA and Latin America)
6 emerging countries represent 20% of the growth (Russia,
Turkey, South Korea, China, India and Brasil)
Prescription
OTC
Dermopharmacy: Patches
50%
Dermopharmaceutical
Market
Skin application benefits
Local or systemic treatment
Good patient compliance especially when the skin feeling is good
Non invasive
No hepatic first pass
None or slight adverse effect
Main uses
Anti-acne
Anti-aging
Alopecia treatment
Fungal infection
Antisepsis
Anti-inflammatoty
Dermatosis (psoriasis, eczema, pruritis…)
Hormonal treatment
…
Dermopharmaceutical
Market
anti-acne
SAI + NSAI
anti-fungal
antibiotics
others
15%
29%
15%
16% 25%
Turn-over of dermopharmaceutical drugs
according to the use
Companies involved in the
market
2 Marketed Drug forms
What is *Cutaneous penetration?
EXCIPIENTS
• Parameters
Enhance or decrease the cutaneous
absorption
Decrease the absorption
•Cationic polymers (gels)
•Mineral oils (vaseline, silicons…)
Enhance the permeability
•Vegetal oils
•Surfactants
•Liposomes
•Emulsions, multiple emulsions
What is *Cutaneous penetration?
• Parameters
SKIN STATE
The cutaneous barrier efficiency
must be decreased
Use of detergents
Cutaneous moisturisation (patches)
Absorption enhancers
Vasodilators (nicotinates)
Skin disease
Premature
What is *Cutaneous penetration?
• Parameters
API
Cutaneous penetration depends on
the nature of the API
Size (low MW = higher
penetration)
Shape
Nature (hydrophilic, lipophilic,
amphiphilic)
What is *Cutaneous penetration?
Different Ways through the skin:
Penetration kinetics
According to Fick’s law
J = flow
Kp = permeability coefficient
Km . D . ∆c ∆c = difference of concentration
J = flow
Kp = permeability coefficient
Km . D . ∆c ∆c = difference of concentration
J = Kp . ∆c = Km = partition coefficient between
e stratum corneum and excipients
D = diffusion coefficient
e = thickness of stratum corneum
Franz’s cell:
In-vitro cutaneous penetration model
6 cells
Gel
Semi-solid
Ointment
Monophase
Liquid solution
Drug forms
Cream
Gel –
Semi-solid Cream
Foam
Gel In
Multiphase
Oil
Fluid
Liquid
emulsion
Drug forms
Solid Powder
Liquid suspension
Marketed forms
Plaster Gel
Powder
Solution
Ointment
Cream Foam
Fluid
Gel Cream Suspension Emulsion
3 Emulsiology Theory
Emulsion Theory
*Emulsion = Stable mixture of oil and water
Why?
To obtain a specific sensorial profile
To obtain specific technical characteristics
The more the interfacial film is optimized, the more stable the
emulsion
Small size
Low tension
Emulsion Theory
Stability of the emulsions creaming
Stockes’ law and sedimentation
Creaming Sedimentation
Emulsion Theory
Interfacial film
Surfactants
Non-ionic surfactant
Steric hindrance Polymeric emulsifier
Lamellar phase
- (liquid cristal)
Ionic surfactant
Steric hindrance and
-
electrostatic repulsion
-
Insoluble particles
(Pickering’s emulsion)
Emulsion Theory
Non-ionic surfactants
*Non ionic-surfactants
W
W
O
O
Emulsion Theory
Non-ionic surfactants
*Non ionic-surfactants
It is compulsory to work with a pair of surfactant
Creaming or coalescence if not stable
Water
Oil
Hydrophilic
surfactant
Lipophilic
surfactant
Emulsion Theory
Non-ionic surfactants
Molecular Weight MH
Molecular Weight ML
% lipophilic 0% 1% 2% 3% 4% 5%
% hydrophilic 5% 4% 3% 2% 1% 0%
% total 5% 5% 5% 5% 5% 5%
Microscopic
aspect
Viscosity J1 50 cps 50 cps 10 cps 600 cps 10000 cps 15000 cps
% lipophilic 2.1% 2.2% 2.3% 2.4% 2.5% 2.6% 2.7% 2.8% 2.9%
%
2.9% 2.8% 2.7% 2.6% 2.5% 2.4% 2.3% 2.2% 2.1%
hydrophilic
% total 5% 5% 5% 5% 5% 5% 5% 5% 5%
Microscopic
aspect
Viscosity 10 cps 10 cps 10 cps 10 cps 10 cps 10 cps 10 cps 60 cps 300 cp
Stability J1 Stable Stable Stable Stable Stable Stable Stable Stable Stable
Emulsion Theory
Non-ionic surfactants
Visible
Clear Bluish White
droplets
Particules size
10 nm 100 nm 1 µm 100 µm
BENEFITS CHARACTERISATION
Encapsulation
properties
High stability
Focus on some specific forms
Microemulsions
Thermodynamically stable emulsion:
Formulator’s dream!
BENEFITS
Single homogeneous phase
Solubilizing properties
Newtonian behaviour
Nanoemulsion Microemulsion
DRAWBACKS
DIFFICULTY TO FORMULATE
Spontaneous formation with the right composition
Focus on some specific forms
Gels
Gelifying polymers
Water, Heating,…
Focus on some specific forms
Gel Gels
Single phase, hydrophilic actives
Gel cream
2 phases without emulsion process
Anhydrous gel
For water sensitive API (with polar solvents)
Hydroalcoolic gel
Ethanol up to 60%, often used to increase API solubility
Gel-in-Oil
Sustained release form
Nice skin feeling
5 SEPPIC’s New Excipients
SEPINEO ™ SE 68
Challenges
Comfort
CHALLENGES
200000
150000
Viscosité mPa.s
100000
50000
0
0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
% SEPINEO™ P 600
Water
+ Mix at room addition
SEPINEO™ P 600 temperature of Ethanol or Solvents
(1 to 5%) (acetone, glycols, glycerin…)
Cooling down
Concentrations of use:
0.5 à 2.0%
SEPINEO™ P 600 is not sensitive to shear
SEPINEO™ P 600 helps keeping the viscosity over time
Multifunctional Polymer
SEPINEO™ P 600 - Surfactant
Oily phase
+ Room temperature
SEPINEO™ P 600 (1-5%)
Gel cream
ADVANTAGES
Room temperature
No high shear stress
No need of surfactants
No HLB calculation
Multifunctional Polymer
SEPINEO™ P 600: Formules
SEPINEO SE 68 5%
HUILE MINERALE 8%
HUILE D’AMANDE DOUCE 7% Placebo cream
Eau QSP 100 %
SEPINEO P600 0.2%
C8-C10 TRIGLYCERIDES 15 %
Eau QSP 100 % Gel - Cream
SEPINEO P600 3%
PROPYLENE GLYCOL
SEPINEO P600
100 %
3%
Anhydrous gel
ETHANOL
Eau QSP
60 %
100%
Hydroalcoholic
SEPINEO P600 4% gel
Multifunctional Polymer
SEPINEO™ SE68
*SEPINEO SE 68 is:
a gluco-lipidic emulsifier from vegetal raw materials
250,0 10000
200,0
viscosité (Pa.s)
1000
contrainte (Pa)
150,0 100,0
HYDROCORTISONE 0.5%
SEPICIDE CI (preservative) 0.2%
SEPICIDE HB (preservative) 0.3%
* SEPPIC étant :
SEPPIC S.A. Head Office SEPPIC Japan Office SEPPIC Italia Srl
22 Terrasse Bellini 75, quai d'Orsay Air Liquide Japan's office Via Quarenghi 27
92806 Puteaux 75007 Paris Granpark Tower 3-4-1 Shibaura 20151 Milano
FRANCE FRANCE Minato-ku, Tokyo 108-8509 ITALY
Tel. : +33 (0)1 42 91 40 00 JAPAN Tel : +39 02 38009110
info.seppic@airliquide.com Tel : +81 3 6414 6725 italy.seppic@airliquide.com
japan.seppic@airliquide.com
SEPPIC Asia Singapore SEPPIC Dubai Office SEPPIC Gmbh SEPPIC Colombia SAS
120 Lower Delta Road # 13 – 11 Dubaï Airport Free Zone Von-der-Wettern-STR.27 Calle 71 n°10-40
Cendex Center West Wing 4, B Block 51149 Köln Edificio Orbe 71 of 401
Singapore 169208P.O. Box _ 54638, Suite 144. Dubaï, GERMANY Bogota
SINGAPORE UAE Tel. : +49 (0) 2203-89830-20 COLOMBIA
Tel : +65 6278 6711 P.O. Box 546638 germany.seppic@airliquide.com Tel : +571 702 44 48
singapore.seppic@airliquide.com Tel : + 971 (4) 2395565 colombia.seppic@airliquide.com
dubai.seppic@airliquide.com